Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
2002 1
2007 3
2008 1
2009 6
2010 5
2011 2
2012 3
2013 4
2014 2
2015 2
2016 3
2017 4
2018 3
2019 4
2020 7
2021 4
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Walusungu
Page 1
Endoscopy nurse as a patient care coordinator: the expanded role of the competent nurse in the gastroenterology setting.
Vuorinen R, Heino E, Meretoja R. Vuorinen R, et al. Gastroenterol Nurs. 2009 Nov-Dec;32(6):410-3. doi: 10.1097/SGA.0b013e3181c53799. Gastroenterol Nurs. 2009. PMID: 20010234
Isoaho, & H. Leino-Kilpi, 2004; R. Meretoja, H. Leino-Kilpi, & A. M. Kaira, 2004). In the gastroenterological endoscopy unit, competent nurses' work role has been expanded to the proficient level. ...
Isoaho, & H. Leino-Kilpi, 2004; R. Meretoja, H. Leino-Kilpi, & A. M. Kaira, 2004). In the gastroenterological endoscop …
Osimertinib induced cardiomyopathy: A case report.
Shinomiya S, Kaira K, Yamaguchi O, Ishikawa K, Kagamu H. Shinomiya S, et al. Medicine (Baltimore). 2020 Sep 25;99(39):e22301. doi: 10.1097/MD.0000000000022301. Medicine (Baltimore). 2020. PMID: 32991436 Free PMC article.
PATIENT CONCERNS: A 76-year old woman was treated with afatinib (40 mg/day) as the 1st line treatment due to recurrence after surgical resection for pulmonary adenocarcinoma. However, she experienced recurrence with positive T790 M, and osimertinib (80 mg/day) was administ …
PATIENT CONCERNS: A 76-year old woman was treated with afatinib (40 mg/day) as the 1st line treatment due to recurrence after surgical resec …
Fragile X-Related Protein FXR1 Controls Human Adenovirus Capsid mRNA Metabolism.
Hajikhezri Z, Kaira Y, Schubert E, Darweesh M, Svensson C, Akusjärvi G, Punga T. Hajikhezri Z, et al. J Virol. 2023 Feb 28;97(2):e0153922. doi: 10.1128/jvi.01539-22. Epub 2023 Feb 7. J Virol. 2023. PMID: 36749074 Free PMC article.
We also show that the FXR1 protein interacts with N6-methyladenosine (m(6)A)-modified MLTU mRNAs, thereby acting as a novel m(6)A reader protein in HAdV-5 infected cells. ...
We also show that the FXR1 protein interacts with N6-methyladenosine (m(6)A)-modified MLTU mRNAs, thereby acting as a novel m( …
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
Imai H, Wasamoto S, Tsuda T, Nagai Y, Kishikawa T, Masubuchi K, Osaki T, Miura Y, Umeda Y, Ono A, Minemura H, Yamada Y, Nakagawa J, Kozu Y, Taniguchi H, Ohta H, Kasai T, Kaira K, Kagamu H. Imai H, et al. Thorac Cancer. 2023 Sep;14(25):2567-2578. doi: 10.1111/1759-7714.15036. Epub 2023 Jul 19. Thorac Cancer. 2023. PMID: 37469246 Free PMC article.
BMI predicted the treatment response-individuals with BMI 22.0 kg/m(2) had longer OS than did those with BMI < 22.0 kg/m(2) (OS: 28.4 vs. 18.4 months, p = 0.0086). ...

BMI predicted the treatment response-individuals with BMI 22.0 kg/m(2) had longer OS than did those with BMI < 22.0 kg/m(2)

…
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.
Wang R, Yamada T, Kita K, Taniguchi H, Arai S, Fukuda K, Terashima M, Ishimura A, Nishiyama A, Tanimoto A, Takeuchi S, Ohtsubo K, Yamashita K, Yamano T, Yoshimura A, Takayama K, Kaira K, Taniguchi Y, Atagi S, Uehara H, Hanayama R, Matsumoto I, Han X, Matsumoto K, Wang W, Suzuki T, Yano S. Wang R, et al. Nat Commun. 2020 Sep 14;11(1):4607. doi: 10.1038/s41467-020-18442-4. Nat Commun. 2020. PMID: 32929081 Free PMC article.
Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non-small cell lung cancer.
Imai H, Naito E, Yamaguchi O, Hashimoto K, Iemura H, Miura Y, Shiono A, Mouri A, Kaira K, Kobayashi K, Kagamu H. Imai H, et al. Thorac Cancer. 2022 May;13(10):1479-1489. doi: 10.1111/1759-7714.14417. Epub 2022 Apr 8. Thorac Cancer. 2022. PMID: 35394119 Free PMC article.
RESULTS: The Eastern Cooperative Oncology Group-performance status (PS) independently predicted the second-line nivolumab monotherapeutic effect; good PS (0-1) correlated with significantly longer PFS (4.3 vs. 1.9 months, log-rank; p = 0.0004) and OS (17.7 vs. 4.6 months, log-ran …
RESULTS: The Eastern Cooperative Oncology Group-performance status (PS) independently predicted the second-line nivolumab monotherapeutic ef …
52 results